ORIC
Oric Pharmaceuticals, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$10.61
$-0.39
(-3.55%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.03B | EPS (ttm) | $-1.65 | Current Price | $10.61 |
| Enterprise Value | $791.54M | Forward EPS | $-1.59 | Previous Close | $11.00 |
| P/E Ratio | - | ROA | -25.23% | 52W High | $14.93 |
| Forward P/E | -6.68 | ROE | -39.73% | 52W Low | $3.90 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $10.14 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $9.99 |
| P/B Ratio | 2.54 | Profit Margin | - | Volume | 1.25M |
| EV/EBITDA | -5.39 | Current Ratio | 14.65 | Avg Volume | 1.49M |
| EV/Sales | - | Quick Ratio | 14.23 | Beta | 1.33 |
| Employees | 106.00 | Debt/Equity | 1.82 | Shares Outstanding | 97.39M |
| Sector | Healthcare | Total Debt | $7.39M | Float Shares | 63.68M |
| Industry | Biotechnology | Total Cash | $287.14M | Short Float | 21.98% |
| Optionable | Yes | Cash/Share | $2.95 | Short Ratio | 12.10 |
| Dividend Yield | - | Book Value/Share | $4.18 | % Held by Insiders | 6.71% |
| Target Price | $21.00 | Revenue (TTM) | - | % Held by Institutions | 107.76% |